Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Interest & Investment Income of $276000.0 for Q1 2026, down 89.4% sequentially from $2.6 million in Q4 2025, and down 73.79% YoY from $1.1 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $276000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 73.79% year-over-year to $276000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 52.35% YoY) and the FY2025 annual result came in at $2.5 million, up 4060.0% from the prior year.
- Interest & Investment Income declined to $276000.0 in Q1 2026 per BOLT's latest filing, from $2.6 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $6.3 million in Q4 2023 and troughed at -$108000.0 in Q4 2024.
- A 5-year average of $1.0 million and a median of $477000.0 in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 23266.67% in 2024, down 101.73% in 2024.
- Over 5 years, Interest & Investment Income stood at $790000.0 in 2022, then jumped by 691.65% to $6.3 million in 2023, then plunged by 101.73% to -$108000.0 in 2024, then soared by 2510.19% to $2.6 million in 2025, then slumped by 89.4% to $276000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $276000.0, $2.6 million, and $477000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Bolt Biotherapeutics | 6.10 Mn | 6.10 Mn | - | 178,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 178,000.00 |
| Mar 31, 2026 | 276,000.00 |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 477,000.00 |
| Jun 30, 2025 | 599,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 790,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 395,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | -684,000.00 |
| Sep 30, 2021 | 131,000.00 |